secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLESENCE, INC. (SLSN)
CIK:        0000883107
Form:       8-K
Filed at:   2025-03-26T23:59:59+00:00
Accession:  0001171843-25-001738
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solésence reports record full-year 2024 revenue of $52.3M, net income of $4.2M vs loss in 2023
--------------------------------------------------------------------------------

- Q4 revenue $12.6M (+57.5% YoY); gross profit $2.8M (22% margin) vs $0.5M (6%) in Q4 2023.
- FY 2024 revenue $52.3M (+40% YoY); net income $4.2M vs net loss $4.4M in FY 2023.
- Company rebranded as Solésence; plans to pursue NASDAQ uplisting and search for dedicated CFO in 2025.
- Initiated expanded batch-making capacity at Bolingbrook facility to support over $200M annual revenue.
- Launched over two dozen new SKUs in prestige and mass beauty; Au Lait Face Milk SPF 50+ won C&T Allē Award.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883107/000117184325001738/0001171843-25-001738-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883107/000117184325001738/f8k_032625.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-001738

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer